Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT01100528Phase 2Completed
Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance
Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma+1 more
PrincipalinvestigatorStart date: 2009-11-11

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Michael McNamara, MD

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center

Moderately Similar
1 trials

Shared therapeutic areas:

Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma+1 more

Worked with same sponsors:

Case Comprehensive Cancer Center
Similarity Score30%

Jeffrey Weber

University of Southern California

Moderately Similar
4 trials

Shared therapeutic areas:

Ciliary Body and Choroid Melanoma, Medium/Large SizeIris MelanomaCiliary Body and Choroid Melanoma, Small Size+1 more
Similarity Score30%

Sapna Patel

M.D. Anderson Cancer Center

Moderately Similar
2 trials

Shared therapeutic areas:

Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma+1 more
Similarity Score30%

Takami Sato, MD

Thomas Jefferson University

Related
2 trials

Shared therapeutic areas:

Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma
Similarity Score23%

Naomi Balzer-Haas

Princess Margaret Hospital Phase 2 Consortium

Related
1 trials

Shared therapeutic areas:

Ciliary Body and Choroid Melanoma, Medium/Large SizeIris MelanomaRecurrent Intraocular Melanoma
Similarity Score23%

Gary Croghan

Mayo Clinic

Related
1 trials

Shared therapeutic areas:

Ciliary Body and Choroid Melanoma, Medium/Large SizeIris MelanomaRecurrent Intraocular Melanoma
Similarity Score23%

Ana Aparicio

SWOG Cancer Research Network

Related
1 trials

Shared therapeutic areas:

Ciliary Body and Choroid Melanoma, Medium/Large SizeIris MelanomaRecurrent Intraocular Melanoma
Similarity Score23%

Elaine McWhirter

Princess Margaret Hospital Phase 2 Consortium

Related
1 trials

Shared therapeutic areas:

Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma
Similarity Score23%

Mitchell Kamrava

Jonsson Comprehensive Cancer Center

Related
2 trials

Shared therapeutic areas:

Iris Melanoma
Similarity Score8%

Paul Chapman

Memorial Sloan Kettering Cancer Center

Related
3 trials

Shared therapeutic areas:

Iris Melanoma
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01100528Phase 2PrincipalInvestigator

Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance

Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma+1 more
Completed

All 1 trials loaded